BIONTECH SE
NASDAQ: BNTX (BioNTech SE)
Kemas kini terakhir: 22 jam lalu87.71
-2.49 (-2.76%)
| Penutupan Terdahulu | 90.20 |
| Buka | 90.14 |
| Jumlah Dagangan | 1,104,149 |
| Purata Dagangan (3B) | 1,210,037 |
| Modal Pasaran | 22,033,135,616 |
| Harga / Pendapatan (P/E Ke hadapan) | 7.04 |
| Harga / Jualan (P/S) | 8.03 |
| Harga / Buku (P/B) | 1.21 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 3 Nov 2026 |
| Margin Keuntungan | -27.89% |
| Margin Operasi (TTM) | -270.46% |
| EPS Cair (TTM) | -3.72 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -2.60% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -43.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.55% |
| Nisbah Semasa (MRQ) | 10.18 |
| Aliran Tunai Operasi (OCF TTM) | -255.70 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -335.98 M |
| Pulangan Atas Aset (ROA TTM) | -3.67% |
| Pulangan Atas Ekuiti (ROE TTM) | -3.94% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | BioNTech SE | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.5 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | -3.0 |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | -2.11 |
|
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 62.69% |
| % Dimiliki oleh Institusi | 22.24% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Davern Capital Partners, Lp | 30 Jun 2026 | 754,550 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| SAHIN UGUR | - | 95.53 | -180,209 | -17,322,855 |
| Jumlah Keseluruhan Kuantiti Bersih | -180,209 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -17,322,855 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 95.53 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| SAHIN UGUR | Pegawai | 09 Oct 2026 | Jual (-) | 36,209 | 96.96 | 3,510,825 |
| SAHIN UGUR | Pegawai | 08 Oct 2026 | Jual (-) | 27,000 | 92.06 | 2,485,620 |
| SAHIN UGUR | Pegawai | 07 Oct 2026 | Jual (-) | 24,000 | 95.25 | 2,286,000 |
| SAHIN UGUR | Pegawai | 06 Oct 2026 | Jual (-) | 21,000 | 95.73 | 2,010,330 |
| SAHIN UGUR | Pegawai | 05 Oct 2026 | Jual (-) | 72,000 | 97.64 | 7,030,080 |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 02 Jun 2022 | - | 17 Jun 2022 | 2.111 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2022 | 2.11 | 1 | 1.41 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |